| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Yoshiharu Matsuura | Q60077839 |
| P2093 | author name string | Kohji Moriishi | |
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 | ||
| Characterization of truncated forms of hepatitis C virus glycoproteins. | Q41091382 | ||
| High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. | Q42990186 | ||
| Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein | Q42999372 | ||
| RNA interference in adult mice. | Q43038702 | ||
| Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children | Q43041183 | ||
| Targeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitors | Q44350630 | ||
| Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers | Q44409476 | ||
| Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection | Q45729692 | ||
| Membrane topology of the hepatitis C virus NS2 protein | Q45732027 | ||
| Combination therapy of chronic hepatitis C: an important step but not the final goal! | Q50587922 | ||
| Human Cytomegalovirus Binding to DC-SIGN Is Required for Dendritic Cell Infection and Target Cell trans-Infection | Q57083074 | ||
| T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections | Q58802894 | ||
| Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation | Q24290542 | ||
| The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus | Q24307963 | ||
| Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
| Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein | Q24319002 | ||
| Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. | Q24524809 | ||
| Structure-function analysis of hepatitis C virus envelope-CD81 binding | Q24525189 | ||
| Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets | Q24534284 | ||
| Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex | Q24537657 | ||
| C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans | Q24537682 | ||
| Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR | Q24551041 | ||
| DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells | Q24673466 | ||
| Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 | ||
| Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor | Q27469307 | ||
| Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
| Cell fusion activity of hepatitis C virus envelope proteins | Q27469594 | ||
| Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines | Q27469636 | ||
| E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies | Q27469693 | ||
| Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation | Q27469769 | ||
| Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations | Q27469794 | ||
| Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively | Q27469877 | ||
| Effect of alpha interferon on the hepatitis C virus replicon | Q27469963 | ||
| Sequences in the 5' nontranslated region of hepatitis C virus required for RNA replication. | Q27469999 | ||
| Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins | Q27472616 | ||
| Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs | Q27472783 | ||
| Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells | Q27472846 | ||
| Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus | Q27472868 | ||
| Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | Q27472869 | ||
| Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles | Q27472884 | ||
| Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins | Q27472885 | ||
| Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry | Q27472900 | ||
| Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype | Q27472930 | ||
| Genetic Analysis of Sequences in the 3' Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication | Q27472973 | ||
| Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees | Q27473004 | ||
| Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs | Q27473092 | ||
| Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture | Q27473339 | ||
| Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture | Q27473345 | ||
| Interference of hepatitis C virus RNA replication by short interfering RNAs | Q27473349 | ||
| L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus | Q27473455 | ||
| Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons | Q27473475 | ||
| The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives | Q27477454 | ||
| Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles | Q27477687 | ||
| Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region | Q27478292 | ||
| Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | Q27485143 | ||
| Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions | Q27485145 | ||
| Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor | Q27485871 | ||
| In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone | Q27488360 | ||
| Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees | Q27489101 | ||
| Efficient initiation of HCV RNA replication in cell culture | Q27860520 | ||
| Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line | Q27860561 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells | Q28138968 | ||
| Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes | Q28206209 | ||
| Identification of signal peptide peptidase, a presenilin-type aspartic protease | Q28206228 | ||
| Novel class of polytopic proteins with domains associated with putative protease activity | Q28215912 | ||
| Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis | Q28511080 | ||
| Mycobacteria target DC-SIGN to suppress dendritic cell function | Q28616857 | ||
| RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals | Q29547713 | ||
| An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells | Q29547714 | ||
| Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease | Q29614208 | ||
| A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells | Q29615897 | ||
| Analysis of a successful immune response against hepatitis C virus | Q29619507 | ||
| Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes | Q29619748 | ||
| Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
| An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A | Q29620628 | ||
| The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine | Q29620670 | ||
| Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection | Q29620702 | ||
| Lack of Protective Immunity Against Reinfection with Hepatitis C Virus | Q29620909 | ||
| Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome | Q29620976 | ||
| The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes | Q30004698 | ||
| Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway | Q30308176 | ||
| The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein | Q30667774 | ||
| Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. | Q33720363 | ||
| Early events in hepatitis C virus infection of chimpanzees. | Q33755441 | ||
| The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy | Q33801327 | ||
| Interaction of hepatitis C virus proteins with host cell membranes and lipids | Q34160337 | ||
| RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells | Q34178401 | ||
| RNA interference: the new somatic cell genetics? | Q34768636 | ||
| Hepatitis C virus therapies: current treatments, targets and future perspectives | Q35147050 | ||
| Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles | Q37249987 | ||
| Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corresponding to the 5' untranslated region of the viral genome | Q38313136 | ||
| Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. | Q38325724 | ||
| Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. | Q40578638 | ||
| Characterization of pseudotype VSV possessing HCV envelope proteins | Q40598617 | ||
| Inhibition of hepatitis B virus in mice by RNA interference | Q40648698 | ||
| Modulation of HIV-1 replication by RNA interference | Q40721798 | ||
| Short interfering RNA confers intracellular antiviral immunity in human cells | Q40721804 | ||
| siRNA-directed inhibition of HIV-1 infection | Q40727988 | ||
| Structural proteins of hepatitis C virus | Q40729931 | ||
| Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells | Q40735249 | ||
| Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase | Q40780476 | ||
| Hepatitis C virus structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stably transfected cells | Q40829716 | ||
| P433 | issue | 6 | |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 285-297 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Antiviral Chemistry & Chemotherapy | Q2853412 |
| P1476 | title | Mechanisms of hepatitis C virus infection | |
| P478 | volume | 14 |
| Q24307609 | A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication |
| Q39366642 | CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan |
| Q47350163 | Characterization of SPP inhibitors suppressing propagation of HCV and protozoa. |
| Q39458949 | Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus |
| Q33799276 | Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules |
| Q39437753 | Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. |
| Q84036104 | Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads |
| Q35040828 | GPS2 is required for the association of NS5A with VAP-A and hepatitis C virus replication |
| Q24306116 | Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 |
| Q24310415 | Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines |
| Q36847659 | Host factors involved in the replication of hepatitis C virus |
| Q24338324 | Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B |
| Q24337683 | Human VAP-C negatively regulates hepatitis C virus propagation |
| Q24305040 | Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication |
| Q40211269 | Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C. |
| Q35376259 | Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics |
| Q40206509 | Interactome of the hepatitis C virus: Literature mining with ANDSystem |
| Q24658154 | Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation |
| Q21560973 | Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutations |
| Q27477612 | Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein |
| Q24795289 | Potential cellular receptors involved in hepatitis C virus entry into cells |
| Q27481021 | Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins |
| Q30155273 | VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B. |
Search more.